Microbiome modulation as a novel therapeutic modality for anxiety disorders: A review of clinical trials
Behavioural Brain Research · 2025
DOI: 10.1016/j.bbr.2025.115595 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Behavioural Brain Research, 2025. Verfasst von Emre Adıgüzel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Karamanoğlu Mehmetbey University, Faculty of Health Sciences, Department of Nutrition and Dietetics, Karaman, Turkey. Electronic address: emreadiguze…. Hauptthemen laut MEDLINE: Anxiety Disorders, Gastrointestinal Microbiome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Anxiety disorders are one of the major conditions in psychiatry characterized by symptoms such as worry, social and performance fears, unexpected and/or triggered panic attacks, anticipatory anxiety, and avoidance behaviors. Recent developments have drawn attention to the putative involvement of peripheral systems in the control of anxiety, and the gut microbiota has come to light as an emerging peripheral target for anxiety. The relationship between the gut-brain axis, a bidirectional communication network between the central nervous system (CNS) and enteric nervous system (ENS), and anxiety has been the subject of some recent studies. Therefore, this systematic review analyzed clinical trials evaluating the potential of microbiome modulation methods in mitigating and ameliorating anxiety disorders. Clinical studies on probiotic, prebiotic, synbiotic supplements, dietary interventions, and fecal microbiota transplantation in anxiety disorders were screened. All of the studies examined the effects of probiotic intervention. One of these studies compared a prebiotic-rich diet with probiotic supplementation. Longitudinal analyses showed that the probiotic intervention alleviated anxiety. However, most of the controlled studies reported that the probiotic intervention did not make a difference compared to placebo. Thus, the current findings suggest that it is too early to consider the promising role of microbiome modulation in the treatment of anxiety disorders. However, it is obvious that more clinical research is needed to clarify issues such as probiotic strains, prebiotic types, and their doses that may be effective on anxiety disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Karamanoğlu Mehmetbey University, Faculty of Health Sciences, Department of Nutrition and Dietetics, Karaman, Turkey. Electronic address: emreadiguzel@kmu.edu.tr.
- Karamanoğlu Mehmetbey University, Faculty of Health Sciences, Department of Nutrition and Dietetics, Karaman, Turkey. Electronic address: semsigulyilmaz@kmu.edu.tr.
- Karamanoğlu Mehmetbey University, Faculty of Health Sciences, Department of Nutrition and Dietetics, Karaman, Turkey. Electronic address: busraatabilen@kmu.edu.tr.
- Karamanoğlu Mehmetbey University, Faculty of Health Sciences, Department of Nutrition and Dietetics, Karaman, Turkey. Electronic address: betulseref@kmu.edu.tr.
Zitieren
APA
Adıgüzel, E., Yılmaz, Ş. G., Atabilen, B., & Şeref, B. (2025). Microbiome modulation as a novel therapeutic modality for anxiety disorders: A review of clinical trials. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2025.115595
Vancouver
Adıgüzel E, Yılmaz ŞG, Atabilen B, Şeref B. Microbiome modulation as a novel therapeutic modality for anxiety disorders: A review of clinical trials. Behavioural Brain Research. 2025. doi:10.1016/j.bbr.2025.115595
BibTeX
@article{Adgzel2025,
author = {Adıgüzel, Emre and Yılmaz, Şemsi Gül and Atabilen, Büşra and Şeref, Betül},
title = {Microbiome modulation as a novel therapeutic modality for anxiety disorders: A review of clinical trials},
journal = {Behavioural Brain Research},
year = {2025},
doi = {10.1016/j.bbr.2025.115595}
}
EUVIMED